@Article{chd.12596,
AUTHOR = {Gareth J. Morgan, Matteo Ciuffreda, Isabella Spadoni, Joseph DeGiovanni},
TITLE = {Optimus covered stent: Advanced covered stent technology for complex congenital heart disease},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {13},
YEAR = {2018},
NUMBER = {3},
PAGES = {458--462},
URL = {http://www.techscience.com/schd/v13n3/39002},
ISSN = {3071-1738},
ABSTRACT = {<b>Aim:</b> To assess the acute results of the first human use of the Optimus covered stent in complex
coarctation of the aorta.<br/>
<b>Methods and Results:</b> We successfully implanted the Optimus covered stent in eight cases in
patients whose preprocedural anatomy looked challenging for currently available covered stents. Six
of the patients had native coarctation with one recoarctation following surgical repair. There were
no significant complications with reduction in the mean invasive gradient from 22 to 1 mm Hg. The
length of stents used ranged from 33 to 57 mm with a median shortening after expansion of 13%.
Postprocedural follow-up with magnetic resonance imaging or computed tomography has not shown
evidence of fracture or migration or renarrowing. The median duration of follow-up is 10 months.<br/>
<b>Conclusions:</b> Preliminary results show that the Optimus covered stent is safe and efficacious for
use in patients with coarctation of challenging morphology. A systemic trial will be required to
evaluate this stent for more widespread practice.},
DOI = {10.1111/chd.12596}
}